Hirofumi Tenshin
Tokushima, 7708504, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Factors secreted from the stem cells of human exfoliated deciduous teeth inhibit osteoclastogenesis through the activation of the endogenous antioxidant system.
Journal: Journal of oral biosciences
Published: December 23, 2024
Developing SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma.
Journal: Cancer cell
Published: October 31, 2024
Myeloma cell growth suppression by osteoblast-derived extracellular vesicles: the creation of a non-permissive niche for myeloma cells by bone-forming osteoblasts.
Journal: Haematologica
Published: September 03, 2024
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Journal: Cancer science
Published: June 04, 2024
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.
Journal: International journal of molecular sciences
Published: April 28, 2024
Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells.
Journal: Haematologica
Published: February 27, 2024
Osteocytes and Paget's Disease of Bone.
Journal: Current osteoporosis reports
Published: February 09, 2024
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
Journal: International journal of hematology
Published: January 04, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
Journal: Antioxidants (Basel, Switzerland)
Published: December 20, 2022
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Journal: Cell reports. Medicine
Published: November 15, 2022
Identification of key determinant for predicting feasible mandibular molars distalization.
Journal: Journal of dental sciences
Published: March 28, 2022
Last Updated: 09/26/2026